Three months after its formation, the DuPont Nutrition & Health Microbiome Venture today announced its second strategic research and development partnership. The newly forged relationship with the Center of Food and Fermentation Technologies (TFTAK) in Tallinn, Estonia, will focus on developing cultivation and bioprocess capabilities for “next-generation” probiotics.
Last November, DuPont Nutrition & Health (DuPont) announced the creation of its Microbiome Venture to spearhead development of new microbiome science-based solutions. Since then, the Microbiome Venture has already taken significant steps in contributing to DuPont’s business growth strategy.
The research and development partnership with TFTAK focuses on cultivation and bioprocess development for “next-generation” probiotics. The term “next generation,” as defined in this partnership, refers to commensal microbes naturally resident in the gastrointestinal tract and demonstrated to be associated with health and wellness. Such microbes typically have fastidious growth requirements, which must be mastered in order to be able to produce them at scale.
“We are delighted to be partnering with TFTAK,” said Microbiome Venture Leader Sebastien Guery. “With its excellent capabilities in bioprocess technology and systems biology, TFTAK will support DuPont by defining the optimum conditions required to culture and produce some of our next-generation probiotic strain candidates.”
Read more here.